EpiBiologics Funding & Investors
San Mateo, CA
EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.
epibiologics.comTotal Amount Raised: $96,050,000
EpiBiologics Funding Rounds
Series A
$23,000,000
Series A Investors
Codon CapitalTaiho VenturesDigitalis VenturesMubadala Capital VenturesPolaris PartnersVivo CapitalGVSeries A
$73,050,000
Series A Investors
Mubadala Capital VenturesPolaris PartnersVivo CapitalGV
Funding info provided by Diffbot.